NPI: 1629009964 · WARREN, OH 44484 · Psychiatric Hospital Unit · NPI assigned 07/05/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 07/05/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 120,479 | $3.95M |
| 2019 | 128,852 | $4.32M |
| 2020 | 83,327 | $4.30M |
| 2021 | 100,539 | $5.18M |
| 2022 | 119,178 | $5.47M |
| 2023 | 300,368 | $11.25M |
| 2024 | 232,762 | $9.17M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 75,732 | 70,474 | $8.91M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 67,624 | 59,860 | $6.32M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 43,583 | 39,145 | $5.24M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22,459 | 19,388 | $2.95M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 28,473 | 27,223 | $2.87M |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,334 | 4,489 | $2.11M |
| 70450 | Computed tomography, head or brain; without contrast material | 8,735 | 7,686 | $2.10M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7,267 | 6,254 | $1.93M |
| 59025 | Fetal non-stress test | 4,416 | 1,306 | $757K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,496 | 1,353 | $713K |
| 80053 | Comprehensive metabolic panel | 54,777 | 45,452 | $550K |
| G0378 | Hospital observation service, per hour | 5,848 | 2,744 | $495K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,800 | 2,733 | $481K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,447 | 1,236 | $412K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,501 | 936 | $376K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,431 | 1,191 | $369K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,054 | 1,937 | $338K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,701 | 2,049 | $324K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,391 | 1,586 | $266K |
| 64483 | 578 | 503 | $240K | |
| 95811 | 308 | 289 | $189K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,079 | 2,008 | $176K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,438 | 766 | $174K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 250 | 232 | $164K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9,470 | 8,441 | $158K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 69,289 | 57,468 | $156K |
| 80048 | Basic metabolic panel (calcium, ionized) | 18,559 | 15,821 | $140K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,848 | 1,549 | $138K |
| 64493 | 239 | 195 | $135K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,498 | 1,314 | $133K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,103 | 605 | $132K |
| 71046 | Radiologic examination, chest; 2 views | 14,906 | 13,711 | $108K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 607 | 526 | $106K |
| 84443 | Thyroid stimulating hormone (TSH) | 5,328 | 4,763 | $101K |
| 83605 | 18,219 | 14,674 | $100K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 389 | 353 | $95K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1,311 | 1,255 | $88K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 357 | 324 | $81K |
| 36415 | Collection of venous blood by venipuncture | 63,080 | 51,984 | $81K |
| 12001 | 493 | 422 | $79K | |
| 47563 | 36 | 25 | $75K | |
| 84484 | 21,873 | 16,933 | $73K | |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 958 | 914 | $73K |
| 00731 | 1,712 | 1,554 | $72K | |
| 70491 | 234 | 193 | $72K | |
| 71271 | 406 | 378 | $61K | |
| 93970 | 430 | 383 | $61K | |
| 85027 | 9,638 | 8,572 | $61K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 622 | 581 | $58K |
| 71250 | 654 | 579 | $57K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,847 | 3,168 | $56K |
| 93971 | 916 | 785 | $56K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,011 | 20,908 | $54K |
| 80061 | Lipid panel | 4,533 | 4,224 | $51K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,157 | 1,075 | $50K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1,856 | 1,647 | $50K |
| 95800 | 151 | 143 | $49K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 340 | 295 | $49K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 399 | 70 | $49K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,475 | 2,321 | $49K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 324 | 307 | $48K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,086 | 3,789 | $43K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 495 | 431 | $43K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 604 | 525 | $43K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 31,073 | 26,386 | $42K |
| 70496 | 154 | 127 | $41K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10,810 | 9,526 | $39K |
| 94060 | 338 | 316 | $38K | |
| 86900 | 1,917 | 1,551 | $38K | |
| 96415 | 256 | 144 | $37K | |
| 62323 | 97 | 94 | $37K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 76 | 67 | $36K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 267 | 256 | $35K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2,639 | 365 | $34K |
| 82728 | 2,162 | 1,976 | $34K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,435 | 475 | $34K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,335 | 3,040 | $34K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 70 | 64 | $34K |
| 76642 | 284 | 257 | $34K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 1,636 | 1,292 | $33K |
| 72131 | 563 | 481 | $33K | |
| 93976 | 338 | 301 | $33K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,316 | 1,983 | $33K |
| 71045 | Radiologic examination, chest; single view | 9,534 | 8,325 | $32K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 677 | 671 | $31K |
| 76536 | 284 | 254 | $30K | |
| 76770 | 181 | 166 | $29K | |
| 93975 | 301 | 226 | $28K | |
| 90791 | Psychiatric diagnostic evaluation | 157 | 138 | $27K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,408 | 1,222 | $27K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 825 | 764 | $25K |
| 81001 | 35,321 | 31,061 | $24K | |
| 82607 | 1,751 | 1,606 | $24K | |
| 76830 | Ultrasound, transvaginal | 558 | 463 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 18,831 | 15,640 | $22K |
| 72100 | 1,159 | 1,041 | $21K | |
| 84439 | 2,059 | 1,856 | $21K | |
| 80305 | 2,095 | 796 | $21K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 355 | 350 | $19K |
| 96367 | 398 | 256 | $18K | |
| 74018 | 936 | 812 | $18K | |
| 80320 | 1,296 | 1,094 | $18K | |
| 94729 | 316 | 299 | $18K | |
| 94726 | 307 | 290 | $17K | |
| 86850 | 1,587 | 1,294 | $17K | |
| 73130 | 1,742 | 1,506 | $16K | |
| 73030 | 1,145 | 1,036 | $15K | |
| 99201 | 273 | 263 | $15K | |
| 83540 | 1,523 | 1,372 | $15K | |
| 73562 | 1,019 | 918 | $15K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,477 | 2,097 | $15K |
| 90714 | 1,029 | 856 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6,758 | 6,409 | $14K |
| 83880 | 3,705 | 2,845 | $14K | |
| 97161 | 492 | 415 | $14K | |
| 73630 | 1,868 | 1,657 | $14K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 17,710 | 14,287 | $13K |
| 12011 | 73 | 71 | $13K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,155 | 1,073 | $13K |
| 12002 | 91 | 79 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,964 | 2,542 | $13K |
| 70486 | 369 | 301 | $12K | |
| 83735 | 6,085 | 4,797 | $12K | |
| 82950 | 819 | 786 | $12K | |
| 86803 | 561 | 502 | $12K | |
| 36591 | 339 | 211 | $11K | |
| 84630 | 769 | 718 | $11K | |
| 83690 | 15,704 | 13,587 | $11K | |
| 73502 | 672 | 605 | $11K | |
| 83550 | 1,440 | 1,296 | $10K | |
| 10060 | 64 | 53 | $10K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 471 | 375 | $10K |
| 84702 | 1,220 | 913 | $10K | |
| 86140 | 1,026 | 814 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,583 | 2,315 | $9K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 463 | 411 | $9K |
| 93017 | 103 | 96 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,580 | 2,314 | $8K |
| 87088 | 4,378 | 3,896 | $8K | |
| 90832 | Psychotherapy, 30 minutes with patient | 69 | 25 | $8K |
| 83970 | 328 | 303 | $8K | |
| 82746 | 1,557 | 1,432 | $8K | |
| 96376 | 2,119 | 1,246 | $8K | |
| 72040 | 242 | 226 | $7K | |
| 49083 | 31 | 12 | $7K | |
| 73610 | 1,417 | 1,245 | $7K | |
| 85610 | 2,499 | 2,026 | $7K | |
| 83516 | 250 | 128 | $7K | |
| 73560 | 722 | 611 | $6K | |
| 84425 | 753 | 704 | $6K | |
| 73221 | 42 | 40 | $6K | |
| 86901 | 1,892 | 1,549 | $6K | |
| 82947 | 1,486 | 1,285 | $6K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 31 | 28 | $6K |
| 84703 | 2,043 | 1,776 | $6K | |
| 82570 | 799 | 709 | $6K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 18 | 13 | $6K |
| 86592 | 435 | 397 | $6K | |
| 86038 | 322 | 268 | $6K | |
| 88307 | 42 | 29 | $6K | |
| 82784 | 464 | 297 | $5K | |
| 87040 | 2,571 | 1,154 | $5K | |
| A9609 | Fludeoxyglucose f18 up to 15 millicuries | 32 | 29 | $5K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 21 | 19 | $5K |
| 84134 | 604 | 555 | $5K | |
| 87340 | 357 | 317 | $5K | |
| 82525 | 327 | 294 | $5K | |
| 73110 | 868 | 767 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,335 | 1,051 | $5K |
| 76820 | 428 | 331 | $5K | |
| 97165 | 160 | 137 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,265 | 1,241 | $5K |
| 97803 | 48 | 46 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 42 | 39 | $5K |
| 81003 | 4,194 | 3,784 | $5K | |
| 86039 | 192 | 157 | $5K | |
| 11045 | 25 | 15 | $4K | |
| 84550 | 682 | 593 | $4K | |
| 76937 | 398 | 327 | $4K | |
| 86703 | 130 | 115 | $4K | |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 59 | 26 | $4K |
| 82962 | 4,786 | 2,836 | $4K | |
| 84100 | 1,263 | 909 | $4K | |
| 84520 | 1,244 | 1,124 | $4K | |
| 70498 | 73 | 67 | $3K | |
| 83615 | 359 | 269 | $3K | |
| 80074 | 149 | 133 | $3K | |
| 73590 | 543 | 468 | $3K | |
| 87081 | 497 | 448 | $3K | |
| 76821 | 188 | 150 | $3K | |
| 76801 | 106 | 94 | $3K | |
| 81025 | 3,972 | 3,632 | $3K | |
| 85730 | 1,450 | 1,186 | $2K | |
| 77336 | 24 | 12 | $2K | |
| 72072 | 118 | 104 | $2K | |
| 85652 | 727 | 609 | $2K | |
| J2800 | Injection, methocarbamol, up to 10 ml | 890 | 720 | $2K |
| 80051 | 837 | 751 | $2K | |
| 72220 | 54 | 51 | $2K | |
| 80143 | 1,667 | 1,379 | $2K | |
| 84590 | 309 | 281 | $2K | |
| 72128 | 83 | 77 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 140 | 116 | $2K |
| 73700 | 21 | 14 | $2K | |
| 82043 | 448 | 433 | $2K | |
| 71101 | 227 | 195 | $2K | |
| 84153 | 109 | 98 | $2K | |
| 82565 | 1,241 | 1,115 | $2K | |
| 72141 | 13 | 13 | $2K | |
| 97014 | 81 | 28 | $2K | |
| 93880 | 25 | 24 | $2K | |
| 80076 | 549 | 421 | $2K | |
| 82248 | 1,116 | 969 | $2K | |
| 88342 | 536 | 479 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 228 | 209 | $2K |
| 84436 | 482 | 425 | $2K | |
| 82465 | 234 | 226 | $2K | |
| 77080 | 39 | 37 | $2K | |
| 86308 | 318 | 272 | $2K | |
| 36430 | 47 | 37 | $2K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 111 | 89 | $2K |
| 73070 | 301 | 264 | $2K | |
| 85651 | 405 | 298 | $2K | |
| 82044 | 220 | 204 | $2K | |
| 72050 | 36 | 26 | $2K | |
| 87210 | 665 | 560 | $2K | |
| 73090 | 297 | 261 | $2K | |
| 76641 | 13 | 12 | $1K | |
| 87634 | 739 | 660 | $1K | |
| 81002 | 8,562 | 3,674 | $1K | |
| 80164 | 131 | 118 | $1K | |
| 85378 | 744 | 618 | $1K | |
| 82378 | 120 | 89 | $1K | |
| 84478 | 301 | 290 | $1K | |
| 87077 | 941 | 747 | $1K | |
| 86481 | 29 | 25 | $1K | |
| 82077 | 657 | 472 | $1K | |
| 77065 | Tomosynthesis, mammo | 55 | 49 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,062 | 2,052 | $1K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,301 | 1,222 | $1K |
| 82550 | 915 | 713 | $1K | |
| 80179 | 1,646 | 1,369 | $1K | |
| 86762 | 63 | 58 | $1K | |
| 84156 | 256 | 209 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 20,975 | 17,880 | $1K |
| J2704 | Injection, propofol, 10 mg | 13,202 | 9,481 | $1K |
| 85014 | 395 | 257 | $903.41 | |
| 82805 | 35 | 25 | $890.24 | |
| 86706 | 35 | 29 | $886.10 | |
| 82977 | 86 | 84 | $880.23 | |
| 77066 | Tomosynthesis, mammo | 44 | 37 | $878.78 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 15 | 15 | $871.64 |
| 86317 | 48 | 39 | $852.75 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,488 | 616 | $822.47 |
| 85379 | 1,202 | 1,082 | $815.93 | |
| 97162 | 12 | 12 | $769.89 | |
| 64494 | 221 | 183 | $729.84 | |
| 87522 | Neg quan hep c or qual rna | 14 | 13 | $728.78 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,636 | 1,755 | $705.20 |
| 87807 | 756 | 701 | $700.25 | |
| 84145 | 180 | 149 | $673.70 | |
| 00840 | 106 | 78 | $610.84 | |
| 88304 | 1,100 | 926 | $607.43 | |
| 87186 | 405 | 276 | $606.82 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 127 | 64 | $583.12 |
| 72170 | 133 | 98 | $578.36 | |
| 85018 | 396 | 258 | $568.93 | |
| 97535 | Self-care/home management training, each 15 minutes | 15 | 12 | $531.50 |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,539 | 1,045 | $522.10 |
| 82140 | 155 | 137 | $509.21 | |
| 84460 | 72 | 70 | $505.25 | |
| 82105 | 68 | 60 | $498.66 | |
| 86431 | 29 | 24 | $497.97 | |
| 73552 | 44 | 39 | $473.27 | |
| C1781 | Mesh (implantable) | 134 | 111 | $456.16 |
| 94618 | 14 | 14 | $436.34 | |
| J1953 | Injection, levetiracetam, 10 mg | 125 | 88 | $426.07 |
| 86787 | 15 | 12 | $392.45 | |
| 87070 | 665 | 495 | $372.80 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 16,414 | 13,067 | $366.49 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,238 | 8,414 | $350.28 |
| 87205 | 598 | 435 | $325.90 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,216 | 904 | $318.73 |
| 90715 | 16 | 13 | $317.61 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 80 | 59 | $316.37 |
| 86704 | 19 | 14 | $309.65 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 870 | 725 | $304.30 |
| 87075 | 177 | 116 | $292.24 | |
| 90688 | 47 | 43 | $277.60 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,484 | 3,454 | $264.89 |
| 82010 | 625 | 519 | $264.30 | |
| 94664 | 415 | 331 | $261.36 | |
| 84146 | 26 | 26 | $252.64 | |
| 73060 | 43 | 39 | $252.02 | |
| 82951 | 12 | 12 | $245.96 | |
| J1453 | Injection, fosaprepitant, 1 mg | 18 | 12 | $228.15 |
| 84481 | 15 | 13 | $224.52 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,935 | 2,950 | $215.32 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 10,766 | 8,924 | $208.03 |
| 01992 | 210 | 201 | $202.68 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 674 | 493 | $178.94 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 65 | 60 | $177.27 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 2,309 | 2,082 | $170.24 |
| 82800 | 576 | 482 | $169.90 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 772 | 596 | $151.70 |
| 82150 | 53 | 49 | $142.31 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 540 | 365 | $131.45 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 270 | 192 | $124.91 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 295 | 237 | $124.38 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,249 | 1,092 | $112.63 |
| 73080 | 13 | 12 | $109.88 | |
| 74022 | 31 | 27 | $108.84 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 409 | 319 | $106.69 |
| 84165 | 17 | 12 | $101.37 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,298 | 1,007 | $95.81 |
| 84112 | 13 | 13 | $83.84 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 8,446 | 7,029 | $73.49 |
| 73521 | 14 | 12 | $70.41 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,873 | 11,965 | $66.72 |
| J2060 | Injection, lorazepam, 2 mg | 598 | 417 | $65.73 |
| 84155 | 17 | 12 | $64.86 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 606 | 495 | $62.78 |
| 86923 | 16 | 12 | $60.54 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 198 | 115 | $46.57 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 247 | 162 | $36.76 |
| J3480 | Injection, potassium chloride, per 2 meq | 548 | 313 | $34.77 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 110 | 79 | $30.21 |
| 86403 | 35 | 27 | $30.10 | |
| J7050 | Infusion, normal saline solution, 250 cc | 368 | 285 | $27.87 |
| J1921 | Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg | 68 | 51 | $25.56 |
| J1790 | Injection, droperidol, up to 5 mg | 201 | 125 | $24.91 |
| 84132 | 29 | 26 | $20.98 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 173 | 92 | $20.24 |
| G0008 | Administration of influenza virus vaccine | 66 | 60 | $19.81 |
| J1171 | Injection, hydromorphone, 0.1 mg | 118 | 86 | $13.24 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 131 | 93 | $12.99 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,220 | 2,679 | $12.90 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 304 | 273 | $11.02 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 536 | 498 | $9.49 |
| J1836 | Injection, metronidazole, 10 mg | 73 | 39 | $8.96 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 91 | 85 | $8.86 |
| J1630 | Injection, haloperidol, up to 5 mg | 48 | 38 | $7.20 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 138 | 91 | $6.85 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 293 | 272 | $4.96 |
| J1940 | Injection, furosemide, up to 20 mg | 85 | 62 | $4.58 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14 | 13 | $4.52 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 208 | 199 | $4.49 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,302 | 1,028 | $3.46 |
| 82731 | 16 | 16 | $3.22 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 789 | 694 | $1.84 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 65 | 56 | $1.35 |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 34 | 33 | $0.31 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,703 | 1,567 | $0.18 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 321 | 270 | $0.00 |
| 00790 | 615 | 527 | $0.00 | |
| C1773 | Retrieval device, insertable (used to retrieve fractured medical devices) | 126 | 113 | $0.00 |
| G0379 | Direct admission of patient for hospital observation care | 538 | 424 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 82 | 68 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 112 | 101 | $0.00 |
| 64484 | 31 | 25 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 35 | 34 | $0.00 |
| 00630 | 16 | 14 | $0.00 | |
| 96368 | 41 | 24 | $0.00 | |
| 01480 | 113 | 95 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 256 | 242 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 31 | 31 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 26 | 26 | $0.00 |
| 94761 | 28 | 26 | $0.00 | |
| 94760 | 27 | 27 | $0.00 | |
| 01400 | 19 | 12 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 76 | 54 | $0.00 |
| 29125 | 44 | 42 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 275 | 192 | $0.00 |
| 74300 | 36 | 25 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 14 | 14 | $0.00 |
| H1000 | Prenatal care, at-risk assessment | 53 | 48 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 15 | 14 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 29 | 24 | $0.00 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 17 | 12 | $0.00 |
| 76818 | 112 | 52 | $0.00 | |
| 64495 | 58 | 55 | $0.00 | |
| C1729 | Catheter, drainage | 210 | 103 | $0.00 |
| C1776 | Joint device (implantable) | 16 | 12 | $0.00 |
| 01810 | 29 | 25 | $0.00 | |
| 00400 | 20 | 14 | $0.00 |